NL-OMON50055招募中不适用
TNFR2 Agonism and the Ex Vivo Expansion of Regulatory T Cells of Patients with Autoimmune or Inflammatory Disease - TNFR2 Agonism and Ex Vivo Expansion of Regulatory T Cells
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patient of the Maastricht University Medical Center (MUMC+) in Maastricht, The Netherlands, or of the Zuyderland Medical Center in Sittard-Geleen, The Netherlands
- •- Diagnosis of respective disease (MS, SLE, AAV, or IBD)
- •- Disease duration <5 years
- •- Ethnicity: Caucasian
- •- Untreated at the time of blood sampling or prednisone treatment of <10 mg/day
- •- Age: 18 * 65 years;Healthy Controls:
- •- Untreated at the time of blood sampling
- •- Ethnicity: Caucasian
- •- Age: 18 * 65 years
排除标准
- •- Proven infections two weeks prior to blood sampling
- •- Strong immunomodulation and/or immunosuppression in the last 3 months
- •- Other diseases: cancer (malignancies)
- •- Pregnancy;Healthy Controls:
- •- Proven infection two weeks prior to blood sampling
- •- Immune-related diseases
- •- Other diseases: cancer (malignancies)
- •- Pregnancy
研究者
相似试验
进行中（未招募）
不适用
Effect of TNFalpha blockade on the induction of specific B cell responses in vivo, using human spondyloarthropathy as model.SpondyloarthropathyEUCTR2004-001113-33-BEniversity Hospital Ghent50
已完成
不适用
Effect of 8 weeks of Pilates exercise and vitamin D on Tumor necrosis factor-a and interleukin-10 levels in overweight meObesity and overweight.Obesity due to excess caloriesE66.0IRCT20190831044650N2Qaemshahr branch, Islamic Azad University56
尚未招募
不适用
Impaired regulation of Toll-like receptor-2 mediated T helper type 1 responses in NOD2/CARD15 deficient Crohn*s disease patients10017969NL-OMON30051Vrije Universiteit Medisch Centrum20
招募中
不适用
Impaired regulation of Toll-like receptor-2 mediated T helper type responses in patients with inflammatory bowel diseaseCrohn's diseaseNL-OMON33624Vrije Universiteit Medisch Centrum40
进行中（未招募）
1 期
GR014: Randomized phase II study of NGR-hTNF in combination with standard chemotherapy versus standard chemotherapy alone in previously untreated patients with advanced non-small cell lung cancer (NSCLC. - NGR014ocally advanced (stage IIIb with supraclavicular lymph node metastases or malignant pleural or pericardial effusion), metastatic (stage IV) or recurrent non-small cell lung cancer.MedDRA version: 9.1Level: LLTClassification code 10061873Term: Non-small cell lung cancerEUCTR2008-002703-20-ITMOLMED102